Clinical Trial: Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Efficacy and Safety of Amphotericin B Deoxycholate Compared to Meglumine Antimoniate for Treatment of Visceral Leishmaniasis in Brazilian Children
Brief Summary: The purpose of this study is to determine if amphotericin B is effective against visceral leishmaniasis in Brazilian children. Amphotericin B will be compared to meglumine antimoniate which is the current approved drug used for this disease in Brazil.
Detailed Summary:
Sponsor: University of Brasilia
Current Primary Outcome: Cure rate [ Time Frame: 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Improvement rate [ Time Frame: 30 days ]
- Adverse events rate [ Time Frame: 30 days ]
Original Secondary Outcome: Same as current
Information By: University of Brasilia
Dates:
Date Received: December 14, 2009
Date Started: October 2007
Date Completion:
Last Updated: March 7, 2011
Last Verified: March 2011
